Publication Information

{'id': 'https://openalex.org/W2740630295', 'doi': 'https://doi.org/10.1158/1538-7445.am2017-46', 'title': 'Abstract 46: Preclinical activity of novel antibody-drug conjugates with pyrrole-based kinesin spindle protein inhibitors targeting different tumor antigens', 'display_name': 'Abstract 46: Preclinical activity of novel antibody-drug conjugates with pyrrole-based kinesin spindle protein inhibitors targeting different tumor antigens', 'publication_year': 2017, 'publication_date': '2017-07-01', 'ids': {'openalex': 'https://openalex.org/W2740630295', 'doi': 'https://doi.org/10.1158/1538-7445.am2017-46', 'mag': '2740630295'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2017-46', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5007299835', 'display_name': 'Anette Sommer', 'orcid': 'https://orcid.org/0000-0002-1576-3110'}, 'institutions': [], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Anette Sommer', 'raw_affiliation_strings': ['1Bayer AG, Berlin, Germany;'], 'affiliations': [{'raw_affiliation_string': '1Bayer AG, Berlin, Germany;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5061581322', 'display_name': 'Sandra Berndt', 'orcid': 'https://orcid.org/0000-0002-9732-9413'}, 'institutions': [], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Sandra Berndt', 'raw_affiliation_strings': ['1Bayer AG, Berlin, Germany;'], 'affiliations': [{'raw_affiliation_string': '1Bayer AG, Berlin, Germany;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5008538262', 'display_name': 'Hans‐Georg Lerchen', 'orcid': 'https://orcid.org/0000-0001-8746-9554'}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Hans-Georg Lerchen', 'raw_affiliation_strings': ['2Bayer AG, Wuppertal, Germany.'], 'affiliations': [{'raw_affiliation_string': '2Bayer AG, Wuppertal, Germany.', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040976235', 'display_name': 'Beatrix Stelte‐Ludwig', 'orcid': 'https://orcid.org/0000-0002-1045-1134'}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Beatrix Stelte-Ludwig', 'raw_affiliation_strings': ['2Bayer AG, Wuppertal, Germany.'], 'affiliations': [{'raw_affiliation_string': '2Bayer AG, Wuppertal, Germany.', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043639915', 'display_name': 'Sven Wittrock', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Sven Wittrock', 'raw_affiliation_strings': ['2Bayer AG, Wuppertal, Germany.'], 'affiliations': [{'raw_affiliation_string': '2Bayer AG, Wuppertal, Germany.', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5026724212', 'display_name': 'Anne‐Sophie Rebstock', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Anne-Sophie Rebstock', 'raw_affiliation_strings': ['2Bayer AG, Wuppertal, Germany.'], 'affiliations': [{'raw_affiliation_string': '2Bayer AG, Wuppertal, Germany.', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078920724', 'display_name': 'Lisa Dietz', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Lisa Dietz', 'raw_affiliation_strings': ['2Bayer AG, Wuppertal, Germany.'], 'affiliations': [{'raw_affiliation_string': '2Bayer AG, Wuppertal, Germany.', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5020518251', 'display_name': 'Christoph Mahlert', 'orcid': 'https://orcid.org/0000-0003-3272-7856'}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Christoph Mahlert', 'raw_affiliation_strings': ['2Bayer AG, Wuppertal, Germany.'], 'affiliations': [{'raw_affiliation_string': '2Bayer AG, Wuppertal, Germany.', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5026172424', 'display_name': 'Simone Greven', 'orcid': 'https://orcid.org/0009-0004-4717-8938'}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Simone Greven', 'raw_affiliation_strings': ['2Bayer AG, Wuppertal, Germany.'], 'affiliations': [{'raw_affiliation_string': '2Bayer AG, Wuppertal, Germany.', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5027574727', 'display_name': 'Nils Griebenow', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Nils Griebenow', 'raw_affiliation_strings': ['2Bayer AG, Wuppertal, Germany.'], 'affiliations': [{'raw_affiliation_string': '2Bayer AG, Wuppertal, Germany.', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5038025671', 'display_name': 'Yolanda Cancho‐Grande', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Yolanda Cancho-Grande', 'raw_affiliation_strings': ['2Bayer AG, Wuppertal, Germany.'], 'affiliations': [{'raw_affiliation_string': '2Bayer AG, Wuppertal, Germany.', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5031243988', 'display_name': 'Rolf Jautelat', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Rolf Jautelat', 'raw_affiliation_strings': ['2Bayer AG, Wuppertal, Germany.'], 'affiliations': [{'raw_affiliation_string': '2Bayer AG, Wuppertal, Germany.', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5038611439', 'display_name': 'Heiner Apeler', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Heiner Apeler', 'raw_affiliation_strings': ['2Bayer AG, Wuppertal, Germany.'], 'affiliations': [{'raw_affiliation_string': '2Bayer AG, Wuppertal, Germany.', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5048269157', 'display_name': 'Bertolt Kreft', 'orcid': None}, 'institutions': [], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Bertolt Kreft', 'raw_affiliation_strings': ['1Bayer AG, Berlin, Germany;'], 'affiliations': [{'raw_affiliation_string': '1Bayer AG, Berlin, Germany;', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.107, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.376967, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 64, 'max': 71}, 'biblio': {'volume': '77', 'issue': '13_Supplement', 'first_page': '46', 'last_page': '46'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T13526', 'display_name': '14-3-3 Proteins: Structure, Function, and Regulation', 'score': 0.9533, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T13526', 'display_name': '14-3-3 Proteins: Structure, Function, and Regulation', 'score': 0.9533, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10755', 'display_name': 'HER2 Signaling in Breast Cancer Treatment', 'score': 0.928, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10492', 'display_name': 'Regulation and Function of Microtubules in Cell Division', 'score': 0.9259, 'subfield': {'id': 'https://openalex.org/subfields/1307', 'display_name': 'Cell Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/linker', 'display_name': 'Linker', 'score': 0.5160832}, {'id': 'https://openalex.org/keywords/protein-protein-interactions', 'display_name': 'Protein-Protein Interactions', 'score': 0.50262}, {'id': 'https://openalex.org/keywords/kinesin', 'display_name': 'Kinesin', 'score': 0.48046774}, {'id': 'https://openalex.org/keywords/payload', 'display_name': 'Payload (computing)', 'score': 0.46706873}, {'id': 'https://openalex.org/keywords/antibody-drug-conjugate', 'display_name': 'Antibody-drug conjugate', 'score': 0.46403575}], 'concepts': [{'id': 'https://openalex.org/C207001950', 'wikidata': 'https://www.wikidata.org/wiki/Q141124', 'display_name': 'In vivo', 'level': 2, 'score': 0.6718533}, {'id': 'https://openalex.org/C147483822', 'wikidata': 'https://www.wikidata.org/wiki/Q103537', 'display_name': 'Antigen', 'level': 2, 'score': 0.5460047}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.5329484}, {'id': 'https://openalex.org/C2780557392', 'wikidata': 'https://www.wikidata.org/wiki/Q523796', 'display_name': 'Linker', 'level': 2, 'score': 0.5160832}, {'id': 'https://openalex.org/C154317977', 'wikidata': 'https://www.wikidata.org/wiki/Q376266', 'display_name': 'Cytotoxic T cell', 'level': 3, 'score': 0.48971918}, {'id': 'https://openalex.org/C159654299', 'wikidata': 'https://www.wikidata.org/wiki/Q79460', 'display_name': 'Antibody', 'level': 2, 'score': 0.4847762}, {'id': 'https://openalex.org/C59006786', 'wikidata': 'https://www.wikidata.org/wiki/Q15319390', 'display_name': 'Kinesin', 'level': 3, 'score': 0.48046774}, {'id': 'https://openalex.org/C134066672', 'wikidata': 'https://www.wikidata.org/wiki/Q1424639', 'display_name': 'Payload (computing)', 'level': 3, 'score': 0.46706873}, {'id': 'https://openalex.org/C202751555', 'wikidata': 'https://www.wikidata.org/wiki/Q221681', 'display_name': 'In vitro', 'level': 2, 'score': 0.46608987}, {'id': 'https://openalex.org/C2777325958', 'wikidata': 'https://www.wikidata.org/wiki/Q1069596', 'display_name': 'Antibody-drug conjugate', 'level': 4, 'score': 0.46403575}, {'id': 'https://openalex.org/C109316439', 'wikidata': 'https://www.wikidata.org/wiki/Q246181', 'display_name': 'Cytotoxicity', 'level': 3, 'score': 0.4413245}, {'id': 'https://openalex.org/C542903549', 'wikidata': 'https://www.wikidata.org/wiki/Q422248', 'display_name': 'Monoclonal antibody', 'level': 3, 'score': 0.42702895}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.4152853}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.23404351}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.17776656}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.1755397}, {'id': 'https://openalex.org/C20418707', 'wikidata': 'https://www.wikidata.org/wiki/Q189933', 'display_name': 'Microtubule', 'level': 2, 'score': 0.14704251}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.14488813}, {'id': 'https://openalex.org/C41008148', 'wikidata': 'https://www.wikidata.org/wiki/Q21198', 'display_name': 'Computer science', 'level': 0, 'score': 0.07576156}, {'id': 'https://openalex.org/C31258907', 'wikidata': 'https://www.wikidata.org/wiki/Q1301371', 'display_name': 'Computer network', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C150903083', 'wikidata': 'https://www.wikidata.org/wiki/Q7108', 'display_name': 'Biotechnology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C158379750', 'wikidata': 'https://www.wikidata.org/wiki/Q214111', 'display_name': 'Network packet', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C111919701', 'wikidata': 'https://www.wikidata.org/wiki/Q9135', 'display_name': 'Operating system', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2017-46', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.79}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W339756260', 'https://openalex.org/W2952267804', 'https://openalex.org/W2476973230', 'https://openalex.org/W2188252428', 'https://openalex.org/W2083651068', 'https://openalex.org/W2047436521', 'https://openalex.org/W2024399865', 'https://openalex.org/W2000386635', 'https://openalex.org/W1974186570', 'https://openalex.org/W132603888'], 'abstract_inverted_index': {'Abstract': [0], 'Antibody-drug': [1], 'conjugates': [2, 51, 347], '(ADCs)': [3, 52], 'are': [4, 8], 'promising': [5, 293], 'agents': [6], 'that': [7, 43], 'developed': [9], 'for': [10, 306, 365], 'targeted': [11], 'delivery': [12], 'of': [13, 24, 35, 73, 92, 110, 113, 134, 139, 151, 220, 234, 260, 300, 309, 344, 361], 'cytotoxic': [14, 28], 'payloads': [15, 67], 'to': [16, 48, 88, 102, 119, 141, 275], 'tumor': [17, 356], 'cells.': [18], 'ADCs': [19, 60, 152, 162, 186, 305], 'share': [20], 'a': [21, 40, 78, 125, 135, 149, 292], 'common': [22], 'design': [23], 'antibody,': [25], 'linker,': [26], 'and': [27, 85, 153, 159, 170, 173, 176, 200, 212, 222, 242, 303], 'payload.': [29, 215], 'Despite': [30], 'significant': [31], 'efforts,': [32], 'the': [33, 93, 108, 111, 132, 209, 213, 251, 298, 307, 362], 'number': [34], 'available': [36], 'payload': [37, 75, 295], 'classes': [38, 76], 'with': [39, 61, 77, 124, 269, 348], 'differentiated': [41], 'mode-of-action': [42, 80], 'can': [44], 'successfully': [45], 'be': [46], 'employed': [47], 'generate': [49], 'antibody-drug': [50, 346], 'is': [53], 'still': [54], 'rather': [55], 'limited.': [56], 'So': [57], 'far,': [58], 'only': [59], 'microtubule': [62], 'depolymerizing': [63], 'or': [64, 166, 264], 'DNA': [65], 'binding': [66], 'have': [68, 98, 288], 'been': [69, 289], 'approved.': [70], 'The': [71], 'identification': [72], 'ADC': [74], 'novel': [79, 136, 345], 'will': [81], 'increase': [82], 'therapeutic': [83, 127], 'options': [84], 'potentially': [86], 'help': [87], 'overcome': [89], 'resistance.': [90], 'Inhibitors': [91], 'kinesin': [94, 350], 'spindle': [95, 351], 'protein': [96, 352], '(KSP/Eg5/KIF11)': [97], 'generated': [99, 148], 'interest': [100], 'due': [101], 'their': [103], 'high': [104], 'anti-tumor': [105, 218, 267], 'activity.': [106], 'However,': [107], 'transfer': [109], 'potency': [112, 189], 'small': [114], 'molecule': [115], 'KSP': [116, 286], 'inhibitors': [117, 287, 353], '(KSPis)': [118], 'highly': [120, 301], 'efficient': [121], 'clinical': [122], 'regimens': [123], 'sufficient': [126], 'window': [128], 'remains': [129], 'challenging.': [130], 'Through': [131], 'conjugation': [133], 'pyrrole': [137], 'subclass': [138], 'KSPis': [140], 'antibodies': [142], 'targeting': [143, 163, 354], 'different': [144, 355], 'cancer': [145, 192, 230], 'antigens,': [146], 'we': [147], 'panel': [150], 'characterized': [154], 'them': [155], 'both': [156, 229], 'in': [157, 160, 180, 190, 226, 250], 'vitro': [158], 'vivo.': [161], 'either': [164], 'EGFR': [165], 'TWEAKR/Fn14': [167], 'showed': [168], 'strong': [169], 'specific': [171, 175], 'internalization': [172], 'displayed': [174], 'potent': [177, 266, 302], 'anti-proliferative': [178], 'efficacy': [179, 219, 268], 'vitro.': [181], 'In': [182, 284], 'cytotoxicity': [183], 'assays,': [184], 'these': [185], 'exhibited': [187], 'sub-nanomolar': [188], 'antigen-positive': [191], 'cell': [193, 231, 238, 244], 'lines': [194], '(EGFR/TWEAKR-pos.': [195], 'NCI-H292;': [196], 'TWEAKR-pos.': [197], 'BxPC3,': [198], 'LoVo)': [199], 'more': [201], 'than': [202], '100-fold': [203], 'selectivity': [204], 'versus': [205], 'non-targeted': [206], 'control-ADC': [207], 'containing': [208], 'same': [210, 214], 'linker': [211], 'Furthermore,': [216], 'selective': [217, 304], 'EGFR-': [221], 'TWEAKR-KSPi-ADCs': [223], 'was': [224], 'demonstrated': [225], 'vivo': [227], 'using': [228], 'line-derived': [232], 'models': [233], 'NSCLC': [235], '(NCI-H292),': [236], 'urothelial': [237], 'carcinoma': [239, 245], '(UCC)': [240], '(KU-19-19),': [241], 'renal': [243], '(A498),': [246], 'as': [247, 249, 277, 279, 291], 'well': [248, 278], 'TWEAKR-positive': [252], 'patient-derived': [253], 'xenograft': [254], 'UCC': [255], 'model': [256], 'BFX469.': [257], 'At': [258], 'doses': [259], '5-10': [261], 'mg/kg': [262], 'qw': [263], 'bw': [265], 'treated-to-control': [270], 'ratios': [271], '(T/C)': [272], 'between': [273], '0.16': [274], '0.28': [276], 'complete': [280], 'regressions': [281], 'were': [282], 'observed.': [283], 'summary,': [285], 'established': [290], 'new': [294], 'class': [296], 'allowing': [297], 'generation': [299], 'treatment': [308], 'solid': [310], 'tumors.': [311], 'Citation': [312], 'Format:': [313], 'Anette': [314], 'Sommer,': [315], 'Sandra': [316], 'Berndt,': [317], 'Hans-Georg': [318], 'Lerchen,': [319], 'Beatrix': [320], 'Stelte-Ludwig,': [321], 'Sven': [322], 'Wittrock,': [323], 'Anne-Sophie': [324], 'Rebstock,': [325], 'Lisa': [326], 'Dietz,': [327], 'Christoph': [328], 'Mahlert,': [329], 'Simone': [330], 'Greven,': [331], 'Nils': [332], 'Griebenow,': [333], 'Yolanda': [334], 'Cancho-Grande,': [335], 'Rolf': [336], 'Jautelat,': [337], 'Heiner': [338], 'Apeler,': [339], 'Bertolt': [340], 'Kreft.': [341], 'Preclinical': [342], 'activity': [343], 'pyrrole-based': [349], 'antigens': [357], '[abstract].': [358], 'In:': [359], 'Proceedings': [360], 'American': [363], 'Association': [364], 'Cancer': [366, 379], 'Research': [367], 'Annual': [368], 'Meeting': [369], '2017;': [370], '2017': [371], 'Apr': [372], '1-5;': [373], 'Washington,': [374], 'DC.': [375], 'Philadelphia': [376], '(PA):': [377], 'AACR;': [378], 'Res': [380], '2017;77(13': [381], 'Suppl):Abstract': [382], 'nr': [383], '46.': [384], 'doi:10.1158/1538-7445.AM2017-46': [385]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2740630295', 'counts_by_year': [{'year': 2018, 'cited_by_count': 1}], 'updated_date': '2024-09-19T02:02:09.294518', 'created_date': '2017-08-08'}